Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $35.15 USD
Change Today 0.00 / 0.00%
Volume 0.0
STDAF On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
As of 8:10 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Axel Müller

Former Chief Production & Development Officer and Member of The Executive Board, Stada-Arzneimittel AG
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

58--
As of Fiscal Year 2014

Background*

Dr. Axel Müller served as the Chief Production & Development Officer of Stada-Arzneimittel AG from September 16, 2010 to August 7, 2013 and served as its Executive Board Member since 2010. Dr. Müller served as an Exclusive Consultant for numerous international Group projects and periodic assumption of operating management tasks in the STADA Group (since 2005 as Vice President, since 2008 as Senior Vice President), among other things, country responsibility for Switzerland ...

Read Full Background

Corporate Headquarters*

Stadastrasse 2-18
Bad Vilbel, -- 61118

Germany

Phone: 49 6101 6030
Fax: 49 6101 603 259

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STDAF:US $35.15 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
€6.6M
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Chief Executive Officer, Member of The Management Council, Director, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee
Dr. Reddy's Laboratories Ltd.
6.3M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STADA ARZNEIMITTEL AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.